Earning Preview: JBT Marel Corporation Q2 revenue is expected to increase by 10.60%, and institutional views are predominantly bullish

Earnings Agent
Apr 27

Abstract

JBT Marel Corporation will report fiscal results on May 04, 2026 Post Market. Our preview compiles the company’s latest guidance and street expectations for revenue, profitability, and EPS, alongside recent institutional commentary and ratings trends since January 01, 2026.

Market Forecast

Consensus for the current quarter points to revenue of 924.85 million US dollars, up 10.60% year over year, with EBIT estimated at 82.75 million (up 11.33% YoY) and EPS at 1.48 (up 77.49% YoY). Building on last quarter’s margin mix, we expect the company to maintain a gross margin framework in the mid-30% area and a net margin in the mid-single digits, translating to a stable adjusted EPS trajectory year over year. Management’s main-business commentary implies steady momentum in Prepared Foods and Beverage Solutions and Protein Solutions; the most promising segment is Prepared Foods and Beverage Solutions with 2.08 billion US dollars in revenue last quarter and robust order activity suggesting healthy YoY expansion.

Last Quarter Review

JBT Marel Corporation delivered revenue of 1.01 billion US dollars, a gross margin of 34.52%, GAAP net profit attributable to the parent company of 53.10 million, a net margin of 5.27%, and adjusted EPS of 1.98, with revenue up 115.57% YoY and adjusted EPS up 16.47% YoY. A key highlight was an outperformance versus prior estimates, with revenue modestly above plan and EPS exceeding consensus, underpinned by better cost discipline and solid execution. Main business highlights show Prepared Foods and Beverage Solutions at 2.08 billion and Protein Solutions at 1.72 billion in trailing-quarter revenue mix, with Prepared Foods and Beverage Solutions leading segment contribution and order pipeline.

Current Quarter Outlook (with major analytical insights)

Main business: Prepared Foods and Beverage Solutions

Prepared Foods and Beverage Solutions remains the company’s largest revenue contributor, anchored by resilient end markets, modernization cycles at consumer-packaged-food and beverage plants, and higher-throughput automation upgrades. While quarterly seasonality can affect large systems shipments, the backlog conversion cadence supports a baseline of high-30% gross margin in this unit given the installed-base mix and aftermarket pull-through. Price realization achieved during 2025 should continue to offset labor and freight inflation, while component availability and lead-time normalization support on-time deliveries and working-capital rotation. With the quarter’s revenue forecast reflecting double-digit YoY growth at the consolidated level, this business is positioned to supply a meaningful portion of EBIT, aided by favorable mix from solutions and upgrades rather than low-margin pass-through equipment.

Most promising business: Protein Solutions

Protein Solutions is positioned for incremental acceleration as poultry, pork, and seafood processors resume deferred capex and deploy digital inspection and yield-optimization technologies. The integration benefits from the Marel combination are becoming more visible in standardized modules, software, and service bundles, which should lift segment-level margins progressively. As customers target throughput, labor safety, and traceability, order quality continues to improve, and the quarter’s build suggests rising attachment rates for software and service contracts that enhance recurring revenue density. Given the forecast EPS growth of 77.49% YoY at the group level, modest operating leverage from Protein Solutions can provide additional upside to consensus if shipment timing breaks favorably.

Key stock-price drivers this quarter

Earnings sensitivity will center on conversion of the large-systems backlog, aftermarket growth, and the cadence of synergy capture post-integration. Margins could surprise if mix tilts toward high-value automation cells and software, whereas weaker mix or installation delays would pressure conversion and free cash flow. Management’s commentary on order intake quality, pricing discipline, and cost synergy run-rate will likely frame the market’s reaction; investors will also parse working-capital trends for evidence that lead times and inventory positioning are normalizing as expected.

Analyst Opinions

Recent institutions skew bullish. A major upgrade moved to Buy from Hold with a price target increase and a constructive multi-year view, citing a recovery across food processing—especially poultry—and synergy progress, with expectations for earnings growth through 2027 and potential M&A reacceleration after 2026 into further processing, prepared foods, and packaging. Broader coverage indicates a majority of published ratings are Buy or better, with a minority Sell view maintained by another large broker earlier in the period. Weighting the available opinions by count places the balance of sentiment as predominantly bullish. The bullish camp argues that population-driven food demand and a rising middle class underpin durable mid-cycle growth, while mix improvement and scale efficiencies support margin resilience; they see the current quarter’s double-digit revenue growth forecast, mid-30% gross margin framework, and high-70% YoY EPS estimate as reinforcing a positive trajectory heading into the print and setting up for potential guidance tightening if backlog conversion stays on track.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10